» Articles » PMID: 12904093

Safety of Antidepressants in the Elderly

Overview
Specialty Pharmacology
Date 2003 Aug 9
PMID 12904093
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Until the 1980s, the two major classes of antidepressants, the tricyclics and the monoamine oxidase inhibitors (MAOIs), were effective but had severe side effects, requiring monitoring by psychiatrists. The past several years have brought new classes of antidepressants that are safer for the patient to take and far easier for the non-psychiatrist to prescribe. Whilst this is of enormous value, it leaves the physician with the dilemma of which one to prescribe. These new antidepressants cannot safely be used interchangeably. This paper will discuss each of the antidepressants presently available, with particular emphasis on safety in the elderly. Drug interactions, side effects and particular challenges to the older patient will be described. The authors will then advise a general strategy for prescribing antidepressants.

Citing Articles

Neuroleptic malignant syndrome and serotonin syndrome: a comparative bibliometric analysis.

Sweileh W Orphanet J Rare Dis. 2024; 19(1):221.

PMID: 38825678 PMC: 11145872. DOI: 10.1186/s13023-024-03227-5.


Effect of documented and undocumented psychiatric conditions on length of stay and discharge destination after total knee arthroplasty.

Lygrisse K, Singh V, Oakley C, Tang A, Zak S, Clair A Arch Orthop Trauma Surg. 2022; 143(3):1571-1578.

PMID: 35318485 DOI: 10.1007/s00402-022-04415-3.


A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples.

Prado C, Watt S, Crowe S Neuropsychol Rev. 2018; 28(1):32-72.

PMID: 29446012 DOI: 10.1007/s11065-018-9369-5.


A Rehabilitation First-Tournament Between Teams of Nursing Home Residents with Chronic Stroke.

House G, Burdea G, Polistico K, Grampurohit N, Roll D, Damiani F Games Health J. 2016; 5(1):75-83.

PMID: 26741697 PMC: 4770848. DOI: 10.1089/g4h.2015.0072.


A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.

Dodd S, Malhi G, Tiller J, Schweitzer I, Hickie I, Khoo J Aust N Z J Psychiatry. 2011; 45(9):712-25.

PMID: 21888608 PMC: 3190838. DOI: 10.3109/00048674.2011.595686.